The global Anti-inflammatory Drugs Market is estimated to be valued at US$ 79,830.2 million in 2020 and is expected to exhibit a CAGR of 8.6% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
The Anti-inflammatory Drugs market refers to the pharmaceutical products that are used to reduce inflammation in the body. These drugs are primarily used to treat various chronic conditions such as rheumatoid arthritis, osteoarthritis, asthma, and inflammatory bowel disease among others. They help in reducing pain, swelling, and redness caused by inflammation, providing immense relief to the patients suffering from these conditions. The need for anti-inflammatory drugs is significantly high due to the rising prevalence of chronic diseases worldwide. These drugs offer several advantages, such as improved quality of life for the patients and reduction in the risk of complications associated with chronic inflammation.
Market Key Trends:
The key trend observed in the anti-inflammatory drugs market is the increasing adoption of biologics. Biologics are a type of anti-inflammatory drugs that are derived from living organisms or contain components of living organisms. They are highly targeted and have shown better results compared to conventional anti-inflammatory drugs. Biologics offer a more personalized approach to treatment and have shown significant efficacy in patients who do not respond to conventional therapies. The growing number of biologic drug approvals by regulatory authorities is driving the market's growth. Moreover, increasing research and development activities in the field of biologics are expected to further fuel the market growth in the coming years.
PEST Analysis:
Political: The political factor in the anti-inflammatory drugs market refers to government regulations and policies that affect the industry. This includes regulations on drug manufacturing, pricing policies, and intellectual property rights. For example, stringent regulations by regulatory authorities such as the FDA in the US can impact the market by delaying the approval of new drugs.
Economic: The economic factor in the anti-inflammatory drugs market relates to the overall economic conditions that influence the demand and affordability of these drugs. Factors such as disposable income, healthcare expenditure, and insurance coverage can impact the market. A growing aging population and rising healthcare expenditure are expected to contribute to the growth of the market.
Social: The social factor in the anti-inflammatory drugs market encompasses societal trends and demographics that affect the demand for these drugs. Increasing prevalence of chronic diseases such as arthritis, inflammatory bowel disease, and asthma is driving the demand for anti-inflammatory drugs. Additionally, lifestyle changes, such as sedentary lifestyles and unhealthy eating habits, are contributing to the market growth.
Technological: The technological factor in the anti-inflammatory drugs market includes advancements in drug delivery systems, research and development, and precision medicine. Technological innovations such as targeted therapies and biologics are driving the market. For example, the development of TNF inhibitors has revolutionized the treatment of inflammatory diseases.
Key Takeaways:
The Global Anti-Inflammatory Drugs Market Demand is expected to witness high growth, exhibiting a CAGR of 8.6% over the forecast period of 2020-2027. The market is projected to reach US$ 79,830.2 million in 2020. Several factors are contributing to this growth, including increasing prevalence of chronic diseases, growing aging population, and technological advancements in drug development.
Regionally, North America is expected to be the fastest-growing and dominating region in the anti-inflammatory drugs market. This can be attributed to the high prevalence of inflammatory diseases, well-established healthcare infrastructure, and presence of major pharmaceutical companies in the region.
Key players operating in the anti-inflammatory drugs market include Pfizer, Inc., GlaxoSmithKline plc, Johnson & Johnson Services Inc., Merck & Company, Inc., Novartis AG, Amgen, Inc., AstraZeneca plc, Eli Lily and Company, AbbVie Inc., F. Hoffmann-La Roche AG, Bristol Myers Squibb Company, Biogen Inc., Sun Pharmaceutical Industries Ltd, Mylan, Inc., Aurobindo Pharma Limited, and Dr. Reddy’s Laboratories among others. These key players are involved in research and development activities, strategic collaborations, and mergers and acquisitions to strengthen their market position and expand their product portfolio.
Read More:
